These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 36653117)

  • 1. Biotransformation of the Novel Myeloperoxidase Inhibitor AZD4831 in Preclinical Species and Humans.
    Jurva U; Weidolf L; Sandinge AS; Leandersson C; Ekdahl A; Li XQ; Antonsson T; Sundell J; Westerlund K; Amilon C; Inghardt T; Gopaul VS
    Drug Metab Dispos; 2023 Apr; 51(4):464-479. PubMed ID: 36653117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Application of Accelerator Mass Spectrometry to Characterize the Mass Balance Recovery and Disposition of AZD4831, a Novel Myeloperoxidase Inhibitor, following Administration of an Oral Radiolabeled Microtracer Dose in Humans.
    Bhattacharya C; Sandinge AS; Bragg RA; Heijer M; Yan J; Andersson LC; Jurva U; Pelay-Gimeno M; Vaes WHJ; de Ligt RAF; Gränfors M; Amilon C; Lindstedt EL; Menakuru SR; Garkaviy P; Weidolf L; Gopaul VS
    Drug Metab Dispos; 2023 Apr; 51(4):451-463. PubMed ID: 36639243
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Species differences in the formation of vabicaserin carbamoyl glucuronide.
    Tong Z; Chandrasekaran A; DeMaio W; Jordan R; Li H; Moore R; Poola N; Burghart P; Hultin T; Scatina J
    Drug Metab Dispos; 2010 Apr; 38(4):581-90. PubMed ID: 20032194
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative
    Solà J; Menargues À; Homedes J; Salichs M; Serafini MT; Encina G
    Drug Metab Lett; 2021; 14(3):206-218. PubMed ID: 34886785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative metabolism of radiolabeled muraglitazar in animals and humans by quantitative and qualitative metabolite profiling.
    Zhang D; Wang L; Raghavan N; Zhang H; Li W; Cheng PT; Yao M; Zhang L; Zhu M; Bonacorsi S; Yeola S; Mitroka J; Hariharan N; Hosagrahara V; Chandrasena G; Shyu WC; Humphreys WG
    Drug Metab Dispos; 2007 Jan; 35(1):150-67. PubMed ID: 17062777
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics, Disposition, and Biotransformation of [
    Weber E; Subramanian R; Rowe W; Graupe M; Ling J; Shen G; Begley R; Sager J; Wolckenhauer S; Rhee M; Palaparthy R; Singh R
    Clin Pharmacokinet; 2024 Feb; 63(2):241-253. PubMed ID: 38236562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In Vivo Metabolite Profiles of an
    Li XQ; Elebring M; Dahlén A; Weidolf L
    Drug Metab Dispos; 2023 Oct; 51(10):1350-1361. PubMed ID: 37429729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolism and excretion of canagliflozin in mice, rats, dogs, and humans.
    Mamidi RN; Cuyckens F; Chen J; Scheers E; Kalamaridis D; Lin R; Silva J; Sha S; Evans DC; Kelley MF; Devineni D; Johnson MD; Lim HK
    Drug Metab Dispos; 2014 May; 42(5):903-16. PubMed ID: 24568888
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biotransformation of nevirapine, a non-nucleoside HIV-1 reverse transcriptase inhibitor, in mice, rats, rabbits, dogs, monkeys, and chimpanzees.
    Riska PS; Joseph DP; Dinallo RM; Davidson WC; Keirns JJ; Hattox SE
    Drug Metab Dispos; 1999 Dec; 27(12):1434-47. PubMed ID: 10570025
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolism and excretion of the novel bioreductive prodrug PR-104 in mice, rats, dogs, and humans.
    Gu Y; Atwell GJ; Wilson WR
    Drug Metab Dispos; 2010 Mar; 38(3):498-508. PubMed ID: 20019245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HPLC-NMR with severe column overloading: fast-track metabolite identification in urine and bile samples from rat and dog treated with [14C]-ZD6126.
    Lenz EM; D'Souza RA; Jordan AC; King CD; Smith SM; Phillips PJ; McCormick AD; Roberts DW
    J Pharm Biomed Anal; 2007 Feb; 43(3):1065-77. PubMed ID: 17030109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disposition of 1-[3-(aminomethyl)phenyl]-N-[3-fluoro-2'- (methylsulfonyl)-[1,1'-biphenyl]-4-yl]-3-(trifluoromethyl)- 1H-pyrazole-5-carboxamide (DPC 423) by novel metabolic pathways. Characterization of unusual metabolites by liquid chromatography/mass spectrometry and NMR.
    Mutlib AE; Shockcor J; Chen SY; Espina RJ; Pinto DJ; Orwat MJ; Prakash SR; Gan LS
    Chem Res Toxicol; 2002 Jan; 15(1):48-62. PubMed ID: 11800597
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolism of intravenous methylnaltrexone in mice, rats, dogs, and humans.
    Chandrasekaran A; Tong Z; Li H; Erve JC; DeMaio W; Goljer I; McConnell O; Rotshteyn Y; Hultin T; Talaat R; Scatina J
    Drug Metab Dispos; 2010 Apr; 38(4):606-16. PubMed ID: 20053817
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolism and excretion of RWJ-333369 [1,2-ethanediol, 1-(2-chlorophenyl)-, 2-carbamate, (S)-] in mice, rats, rabbits, and dogs.
    Mamidi RN; Mannens G; Annaert P; Hendrickx J; Goris I; Bockx M; Janssen CG; Kao M; Kelley MF; Meuldermans W
    Drug Metab Dispos; 2007 Apr; 35(4):566-75. PubMed ID: 17220243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo metabolism of a new anticancer agent, 6-N-formylamino-12, 13-dihydro-1,11-dihydroxy-13-(beta-D-glucopyranosil)5H-indolo [2,3-a]pyrrolo [3,4-c]carbazole-5,7(6H)-dione (NB-506) in rats and dogs: pharmacokinetics, isolation, identification, and quantification of metabolites.
    Takenaga N; Ishii M; Nakajima S; Hasegawa T; Iwasa R; Ishizaki H; Kamei T
    Drug Metab Dispos; 1999 Feb; 27(2):205-12. PubMed ID: 9929504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro and in vivo metabolism of a gamma-secretase inhibitor BMS-299897 and generation of active metabolites in milligram quantities with a microbial bioreactor.
    Zhang D; Hanson R; Roongta V; Dischino DD; Gao Q; Sloan CP; Polson C; Keavy D; Zheng M; Mitroka J; Yeola S
    Curr Drug Metab; 2006 Dec; 7(8):883-96. PubMed ID: 17168689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolism and Mass Balance of the Novel Nonsteroidal Androgen Receptor Inhibitor Darolutamide in Humans.
    Taavitsainen P; Prien O; Kähkönen M; Niehues M; Korjamo T; Denner K; Nykänen P; Vuorela A; Jungmann NA; von Bühler CJ; Koskinen M; Zurth C; Gieschen H
    Drug Metab Dispos; 2021 Jun; 49(6):420-433. PubMed ID: 33785516
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolism and excretion of loratadine in male and female mice, rats and monkeys.
    Ramanathan R; Alvarez N; Su AD; Chowdhury S; Alton K; Stauber K; Patrick J
    Xenobiotica; 2005 Feb; 35(2):155-89. PubMed ID: 16019945
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of a novel N-carbamoyl glucuronide: in vitro, in vivo, and mechanistic studies.
    Gunduz M; Argikar UA; Baeschlin D; Ferreira S; Hosagrahara V; Harriman S
    Drug Metab Dispos; 2010 Mar; 38(3):361-7. PubMed ID: 20008038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Species difference in glucuronidation formation kinetics with a selective mTOR inhibitor.
    Berry LM; Liu J; Colletti A; Krolikowski P; Zhao Z; Teffera Y
    Drug Metab Dispos; 2014 Apr; 42(4):707-17. PubMed ID: 24423753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.